Back
Apollo Global Management Vs. Akero Therapeutics Industry Stock Comparison
Sell
45
APO
Apollo Global Management
Last Price:
72.97
Seasonality Move:
1.56%
Buy
71
AKRO
Akero Therapeutics
Last Price:
52.46
Seasonality Move:
28.46%
Sell
45
Apollo Global Management (APO)
is a Sell
Is Apollo Global Management a Buy, Sell or Hold?
- The current Apollo Global Management [APO] share price is $72.98. The Score for APO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- APO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $52.49. The Score for AKRO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APO Stock Price Chart
What is Apollo Global Management's stock price today?
-
The Apollo Global Management share price today is $72.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
APO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.45 | Buy |
| Relative Strength Index (14 RSI): | 74.39 | Buy |
| Chaikin Money Flow: | 464002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.13 - 69.37) | Buy |
| Bollinger Bands (100): | (60.94 - 70.64) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.96 | Buy |
| Relative Strength Index (14 RSI): | 67.52 | Buy |
| Chaikin Money Flow: | -176314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.13 - 49.81) | Buy |
| Bollinger Bands (100): | (40.3 - 48.16) | Buy |
APO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.41 | Buy |
| 20-day SMA: | 66.59 | Buy |
| 50-day SMA: | 64.26 | Buy |
| 200-day SMA: | 62.25 | Buy |
| 8-day EMA: | 70.55 | Buy |
| 20-day EMA: | 67.68 | Buy |
| 50-day EMA: | 65.51 | Buy |
| 200-day EMA: | 63.21 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.59 | Buy |
| 20-day SMA: | 47.06 | Buy |
| 50-day SMA: | 44.02 | Buy |
| 200-day SMA: | 40.68 | Buy |
| 8-day EMA: | 50.1 | Buy |
| 20-day EMA: | 47.78 | Buy |
| 50-day EMA: | 45.53 | Buy |
| 200-day EMA: | 39.27 | Buy |
Apollo Global Management Earnings Growth & APO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.23 per share, an increase this year of $1.27 per share, and an increase next year of $1.19 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Apollo Global Management Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||